This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

​Rowsley to buy Thomson Medical businesses in Singapore, Malaysia for $1.2 billion

( December 18, 2017, 07:44 GMT | Official Statement) -- MLex Summary: Singapore-listed Rowsley, an investment company with businesses in design and engineering, real estate development and hospitality, has signed an agreement to acquire Sasteria Pte. Ltd. for S$1.6 billion ($1.2 billion). This will give Rowsley full ownership of Thomson Medical, Singapore’s largest private provider of healthcare services for women and children, and a 70.36 percent stake in Bursa Malaysia-listed TMC Life Sciences, the leading provider of in-vitro fertilization services in Malaysia. The transaction is subject to regulatory approval.The company's full statement is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login